These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 1009233
1. A controlled trial of long-term chelation therapy in homozygous beta-thalassemia. Letsky EA. Birth Defects Orig Artic Ser; 1976; 12(8):31-41. PubMed ID: 1009233 [No Abstract] [Full Text] [Related]
2. Management of thalassemia in Los Angeles. Hyman CB, Ortega JA, Costin G, Landing B, Lazerson J, Leimbrock S, Lurie P. Birth Defects Orig Artic Ser; 1976; 12(8):43-52. PubMed ID: 1009234 [No Abstract] [Full Text] [Related]
3. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia. Kattamis C, Lagos P, Langona E. Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060 [No Abstract] [Full Text] [Related]
6. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine. Giardina PJ, Grady RW. Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288 [Abstract] [Full Text] [Related]
7. Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid. Peterson CM, Graziano JH, Grady RW, Jones RL, Markenson A, Lavi U, Canale V, Gray GF, Cerami A, Miller DR. Exp Hematol; 1979 Feb; 7(2):74-80. PubMed ID: 371974 [Abstract] [Full Text] [Related]
8. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents]. Esposito L, Ferrara M, Ponte G. Pediatria (Napoli); 1981 Sep 30; 89(3):479-92. PubMed ID: 7346759 [No Abstract] [Full Text] [Related]
9. Measurement of iron status. Pippard MJ. Prog Clin Biol Res; 1989 Sep 30; 309():85-92. PubMed ID: 2675108 [No Abstract] [Full Text] [Related]
12. Thalassemia in Italy: treatment of Cooley disease and iron kinetics in heterozygotes. Rotoli B. Birth Defects Orig Artic Ser; 1976 Sep 30; 12(8):53-61. PubMed ID: 1009235 [Abstract] [Full Text] [Related]
13. Iron metabolism in thalassemia intermedia. Fiorelli G, Fargion S, Piperno A, Battafarano N, Cappellini MD. Haematologica; 1990 Sep 30; 75 Suppl 5():89-95. PubMed ID: 2086386 [Abstract] [Full Text] [Related]
14. Current management of homozygous beta thalassemia. Choudhry VP, Desai N, Pati HP, Nanu A. Indian Pediatr; 1991 Oct 30; 28(10):1221-9. PubMed ID: 1724659 [No Abstract] [Full Text] [Related]
16. Liver iron stores before and after bone marrow transplantation for thalassemia. Politi P, Lucarelli G, Capriotti L, Salvadori P, Dardanelli C, Barbanti I. Prog Clin Biol Res; 1989 Oct 30; 309():281-9. PubMed ID: 2675096 [No Abstract] [Full Text] [Related]
17. Hepatic iron stores in thalassemia: non-invasive magnetic measurements. Brittenham GM, Allen CJ, Farrell DE, Harris JW. Prog Clin Biol Res; 1989 Oct 30; 309():101-6. PubMed ID: 2780744 [No Abstract] [Full Text] [Related]
18. [Chelating therapy in beta-thalassemia]. Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G. Pediatr Med Chir; 1982 Oct 30; 4(1-2):55-9. PubMed ID: 7111040 [Abstract] [Full Text] [Related]
19. Serum ferritin in children with thalassaemia regularly transfused. Letsky EA, Miller F, Worwood M, Flynn DM. J Clin Pathol; 1974 Aug 30; 27(8):652-5. PubMed ID: 4421996 [Abstract] [Full Text] [Related]